Syncell has secured $15 million in Series A funding to advance the global commercialization of its innovative Microscoop® technology for protein purification and spatial proteomics.

Target Company Overview

Syncell, a pioneering enterprise in subcellular protein purification and spatial proteomics analysis, was established in 2020 by a team from the Academia Sinica in Taiwan. The company has developed the innovative Microscoop® platform, the world's first 'grab-and-go' microscope, which utilizes artificial intelligence algorithms to selectively capture proteins and nucleic acids from target cellular locations for detailed analysis. As of December 11, 2024, Syncell has successfully concluded a Series A funding round, securing a total of $15 million, bringing its cumulative funding to $30 million. These funds will facilitate the global commercialization of the Microscoop® technology and accelerate advancements in protein purification and spatial proteomics.

The Microscoop® Mint instruments are set to be deployed across the United States, Europe, and Asia by the end of the year, establishing a robust commercial infrastructure to better serve researchers globally.

Industry Overview in Taiwan

Taiwan's biotechnology sector has experienced significant growth in recent years, driven by a strong emphasis on research and innovation. The government has initiated multiple programs to foster biotech development,